Nasic (Xylometazoline Hydrochloride, Dexpanthenol)

Xylometazoline is a selective alpha‑adrenergic agonist. When applied to the nasal mucosa it binds to alpha‑1 receptors on the smooth muscle of nasal blood vessels, causing vasoconstriction. This reduces swelling and excess mucus, opening the airway. Dexpanthenol simultaneously promotes mucosal healing and moisturisation.

The exact dosing regimen for Nasic is determined by the prescribing healthcare professional based on the patient’s age, severity of symptoms and clinical judgment. The product label provides standard instructions, but patients should follow the dose prescribed by their doctor or pharmacist.

Safety data for Nasic in pregnancy and lactation are limited. Women who are pregnant, planning a pregnancy, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using the spray.

To order Nasic, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Nasic combines a fast‑acting decongestant (xylometazoline) with a mucosal‑protective agent (dexpanthenol), whereas many alternatives such as oxymetazoline contain only the vasoconstrictor. The added dexpanthenol may reduce dryness and support healing, potentially offering better tolerability for short‑term use.

Store Nasic at room temperature, preferably below 25 °C, in its original container. Keep the bottle tightly closed, protect it from moisture and direct sunlight, and keep it out of reach of children.

Nasic is sprayed into each nostril while the head is upright. Typically, one or two sprays per nostril are used, but the exact number should follow the prescribing clinician’s instructions. The spray should be directed away from the nasal septum to minimise irritation.

Serious adverse events are rare but may include severe nosebleeds (epistaxis), allergic reactions such as rash, swelling, or anaphylaxis, and a sudden increase in blood pressure. If any of these occur, discontinue use immediately and seek medical attention.

Nasic should be avoided in individuals with known hypersensitivity to xylometazoline, dexpanthenol or any excipients, in patients with severe hypertension or uncontrolled cardiovascular disease, and in children younger than the age specified on the label unless a physician advises otherwise.